AXIN2 and colorectal carcinoma: Similar to the results identified in the single agent experiments, AZ1366 and AZ1366 + irinotecan enhanced Axin2 stabilization; however, there was no reduction in β-catenin (active or nuclear β-catenin) or WNT dependent signaling after treatment in the combination sensitive CRC explants.